Pharma stocks face volatility on us plan to reduce drug prices

Companies in the news ...and how they were assessed

Stocks are living their best life while the dollar is having its worst year since 1973

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say

Europe has been a winner while US has been a (relative) loser

“A latter-day Rip Van Winkle… napping since the start of the year, might think not much had changed” over the past six months in financial markets, says Randall Forsyth in Barron’s. The S&P 500 index

Picking through a murky market outlook for the rest of 2025